Marshall Wace North America’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$581K Buy
+8,736
New +$682K ﹤0.01% 1080
2020
Q4
Sell
-5,552
Closed -$719K 1525
2020
Q3
$719K Buy
+5,552
New +$730K ﹤0.01% 886
2020
Q2
Sell
-435
Closed -$33K 1409
2020
Q1
$33K Sell
435
-29,224
-99% -$2.71M ﹤0.01% 1111
2019
Q4
$3.01M Buy
+29,659
New +$2.94M 0.01% 487
2019
Q3
Sell
-2,390
Closed -$277K 1491
2019
Q2
$277K Buy
+2,390
New +$257K ﹤0.01% 987
2018
Q2
Sell
-2,658
Closed -$312K 1626
2018
Q1
$312K Buy
+2,658
New +$300K ﹤0.01% 1253
2013
Q4
$4.7M Buy
+65,973
New +$5.11M 0.1% 194

Other funds holding PRLB

Marshall Wace North America's PRLB Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Protolabs (PRLB) in Q3 2021: 8,736 shares worth $581K. The stake represents ﹤0.01% of the portfolio and ranks #1080 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in PRLB as recently as Q3 2020.

Marshall Wace North America first reported a position in PRLB in Q4 2013 and has held it in 7 quarters since. The position peaked at $4.7M in Q4 2013. 263 funds tracked by Wall St. Rank hold PRLB as of Q3 2021.

  • Marshall Wace North America held 8,736 shares of Protolabs worth $581K as of Q3 2021.
  • Protolabs was a new Marshall Wace North America position in Q3 2021.
  • Protolabs made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1080 holding.
  • Marshall Wace North America first reported a position in Protolabs in Q4 2013 and has held it in 7 quarters since.
  • Marshall Wace North America's Protolabs position peaked at $4.7M in Q4 2013.
  • 263 funds tracked by Wall St. Rank held Protolabs as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.